Spago Nanomedical AB (publ) (STO:SPAGO)
Sweden
· Delayed Price · Currency is SEK 0.3390
+0.0540 (18.95%)
Jun 25, 2025, 12:52 PM CET
Spago Nanomedical AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 1.9 | 1.91 | 1.2 | 4.75 | 4.92 | 6.11 | Upgrade
|
| Other Revenue | 4.84 | 4.74 | 4.44 | 1.46 | 1.57 | 1.05 | Upgrade
|
| Revenue | 6.73 | 6.65 | 5.64 | 6.2 | 6.48 | 7.16 | Upgrade
|
| Revenue Growth (YoY) | 17.67% | 17.94% | -9.06% | -4.30% | -9.48% | -62.23% | Upgrade
|
| Cost of Revenue | 13.91 | 14.27 | 24.49 | 20.35 | 21.69 | 6.53 | Upgrade
|
| Gross Profit | -7.17 | -7.62 | -18.84 | -14.15 | -15.21 | 0.63 | Upgrade
|
| Selling, General & Admin | 25.4 | 25.71 | 23.67 | 24.84 | 23.53 | 19.31 | Upgrade
|
| Other Operating Expenses | -0.1 | -0.26 | -0.29 | -0.26 | -0.05 | -0.08 | Upgrade
|
| Operating Expenses | 25.59 | 25.76 | 23.66 | 24.94 | 23.86 | 19.59 | Upgrade
|
| Operating Income | -32.77 | -33.38 | -42.51 | -39.09 | -39.07 | -18.95 | Upgrade
|
| Interest Expense | -0.12 | - | - | - | - | - | Upgrade
|
| Interest & Investment Income | 1.04 | 1.2 | 0.85 | 0.27 | 0.12 | 0.03 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.33 | -0.33 | -0.57 | -0.38 | -0.13 | -0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | 0 | - | - | - | 0 | -0 | Upgrade
|
| EBT Excluding Unusual Items | -32.18 | -32.51 | -42.22 | -39.2 | -39.07 | -18.93 | Upgrade
|
| Pretax Income | -32.18 | -32.51 | -42.22 | -39.2 | -39.07 | -18.93 | Upgrade
|
| Earnings From Continuing Operations | -32.18 | -32.51 | -42.22 | -39.2 | -39.07 | -18.93 | Upgrade
|
| Net Income | -32.18 | -32.51 | -42.22 | -39.2 | -39.07 | -18.93 | Upgrade
|
| Net Income to Common | -32.18 | -32.51 | -42.22 | -39.2 | -39.07 | -18.93 | Upgrade
|
| Shares Outstanding (Basic) | 327 | 295 | 98 | 64 | 39 | 27 | Upgrade
|
| Shares Outstanding (Diluted) | 327 | 295 | 98 | 64 | 39 | 27 | Upgrade
|
| Shares Change (YoY) | 149.19% | 201.51% | 52.68% | 62.83% | 45.01% | 35.32% | Upgrade
|
| EPS (Basic) | -0.10 | -0.11 | -0.43 | -0.61 | -0.99 | -0.70 | Upgrade
|
| EPS (Diluted) | -0.10 | -0.11 | -0.43 | -0.61 | -0.99 | -0.70 | Upgrade
|
| Free Cash Flow | -30.78 | -34.9 | -45.06 | -38.32 | -35.94 | -19.38 | Upgrade
|
| Free Cash Flow Per Share | -0.09 | -0.12 | -0.46 | -0.60 | -0.91 | -0.71 | Upgrade
|
| Gross Margin | -106.50% | -114.44% | - | -228.06% | -234.58% | 8.82% | Upgrade
|
| Operating Margin | -486.58% | -501.64% | -753.37% | -630.00% | -602.61% | -264.65% | Upgrade
|
| Profit Margin | -477.89% | -488.56% | -748.37% | -631.80% | -602.67% | -264.28% | Upgrade
|
| Free Cash Flow Margin | -457.13% | -524.45% | -798.69% | -617.68% | -554.40% | -270.57% | Upgrade
|
| EBITDA | -32.47 | -33.07 | -42.22 | -38.73 | -38.69 | -18.59 | Upgrade
|
| EBITDA Margin | - | - | - | - | - | -259.59% | Upgrade
|
| D&A For EBITDA | 0.3 | 0.31 | 0.28 | 0.36 | 0.38 | 0.36 | Upgrade
|
| EBIT | -32.77 | -33.38 | -42.51 | -39.09 | -39.07 | -18.95 | Upgrade
|
| EBIT Margin | - | - | - | - | - | -264.65% | Upgrade
|
| Revenue as Reported | 6.99 | 6.91 | 5.93 | 6.46 | 6.53 | 7.25 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.